Cargando…
Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves’ disease
The aim of the present study was to determine whether the expression levels of interleukin (IL)-2 and IL-10 may be used as biological markers in Graves’ disease (GD) patients. A total of 256 individuals, including 118 GD patients and 138 healthy individuals, were enrolled into the study. Blood sampl...
Autores principales: | LIANG, CUIGE, DU, WENHUA, DONG, QINGYU, LIU, XIAOMENG, LI, WENXIA, WANG, YUELI, GAO, GUANQI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4316959/ https://www.ncbi.nlm.nih.gov/pubmed/25667655 http://dx.doi.org/10.3892/etm.2015.2180 |
Ejemplares similares
-
Investigation of Interleukin-10 Promoter Polymorphisms and Interleukin-10 Levels in Children with Irritable Bowel Syndrome
por: Hua, Man-Chin, et al.
Publicado: (2013) -
Interleukin 6 and 10 Serum Levels and Genetic Polymorphisms in Children with Down Syndrome
por: Mattos, Marlon Fraga, et al.
Publicado: (2018) -
Serum Levels of Interleukin-6 and Interleukin-10 as Biomarkers for Hepatocellular Carcinoma in Egyptian Patients
por: Othman, Mohamed S., et al.
Publicado: (2013) -
Interleukin – 17 and Interleukin-10 as Inflammatory and Prevention Biomarkers in Periimplant Diseases
por: Farhad, Shirin Zahra, et al.
Publicado: (2019) -
Decreased serum interleukin‐41/Metrnl levels in patients with Graves' disease
por: Gong, Luping, et al.
Publicado: (2022)